ArticleInterdisciplinary sciences, computational life sciences2026
AIP-TranLAC: A Transformer-Based Method Integrating LSTM and Attention Mechanism for Predicting Anti-inflammatory Peptides.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Anti-inflammatory peptides (AIPs) have emerged as potential therapeutic candidates for managing various inflammatory disorders, but their computational identification remains challenging. We propose AIP-TranLAC, a novel deep learning framework that integrates Transformer-based embedding, bidirectional long short-term memory (Bi-LSTM), multi-head attention, and convolutional neural network (CNN) to classify AIPs accurately. Our model achieves superior performance on benchmark and independent test datasets, demonstrating significant improvements over existing methods. The hybrid architecture effectively captures local and global sequence patterns, while interpretability analyses reveal critical amino acid residues. With robust performance on imbalanced data and open-source availability, AIP-TranLAC provides a powerful tool for accelerating therapeutic peptide discovery and inflammation research. For reproducibility purposes, we have released the codebase, trained models, and all supporting data on GitHub ( https://github.com/Renjingyi123/AIP-TranLAC ).
Indexed as
Identifiers
40830309What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.